当前位置:首页 > 文献互助 > 互助详情

Technology and innovation: A brief history of Ojjaar (momelotinib) approved by the FDA, discovered in Melbourne复制

用户wEPMgFb_HJo8 24天前 43 10 已关闭

DOI:复制

文献链接:复制

其他信息:

C Burns
Chemistry in Australia, 2023
search.informit.org
On 15 September 2023, the US Food and Drug Administration (FDA) announced that momelotinib, an orally bioavailable JAK1/JAK2 kinase inhibitor (JAK1 and JAK2 being enzymes …

互助时间线

2025-09-15 17:37:55 [关闭求助]

系统关闭了求助

2025-09-10 17:37:55 [发起求助]